» Articles » PMID: 21360186

Long Range Molecular Dynamics Study of Regulation of Eukaryotic Glucosamine-6-phosphate Synthase Activity by UDP-GlcNAc

Overview
Journal J Mol Model
Publisher Springer
Specialty Molecular Biology
Date 2011 Mar 2
PMID 21360186
Citations 3
Authors
Affiliations
Soon will be listed here.
Abstract

Glucosamine-6-phosphate (GlcN-6-P) synthase catalyses the first and practically irreversible step in hexosamine metabolism. The final product of this pathway, uridine 5' diphospho N-acetyl-D-glucosamine (UDP-GlcNAc), is an essential substrate for assembly of bacterial and fungal cell walls. Moreover, the enzyme is involved in phenomenon of hexosamine induced insulin resistance in type II diabetes, which makes it a potential target for antifungal, antibacterial and antidiabetic therapy. The crystal structure of the isomerase domain of GlcN-6-P synthase from human pathogenic fungus Candida albicans, in complex with UDP-GlcNAc has been solved recently but it has not revealed the molecular mechanism of inhibition taking place under UDP-GlcNAc influence, the unique feature of the eukaryotic enzyme. UDP-GlcNAc is a physiological inhibitor of GlcN-6-P synthase, binding about 1 nm away from the active site of the enzyme. In the present work, comparative molecular dynamics simulations of the free and UDP-GlcNAc-bounded structures of GlcN-6-P synthase have been performed. The aim was to complete static X-ray structural data and detect possible changes in the dynamics of the two structures. Results of the simulation studies demonstrated higher mobility of the free structure when compared to the liganded one. Several amino acid residues were identified, flexibility of which is strongly affected upon UDP-GlcNAc binding. Importantly, the most fixed residues are those related to the inhibitor binding process and to the catalytic reaction. The obtained results constitute an important step toward understanding of mechanism of GlcN-6-P synthase inhibition by UDP-GlcNAc molecule.

Citing Articles

Updating the Pharmacological Effects of α-Mangostin Compound and Unraveling Its Mechanism of Action: A Computational Study Review.

Suhandi C, Wilar G, Narsa A, Mohammed A, El-Rayyes A, Muchtaridi M Drug Des Devel Ther. 2024; 18:4723-4748.

PMID: 39469723 PMC: 11514645. DOI: 10.2147/DDDT.S478388.


Understanding Russell's viper venom factor V activator's substrate specificity by surface plasmon resonance and in-silico studies.

Yadav P, Antonyraj C, Basheer Ahamed S, Srinivas S PLoS One. 2017; 12(7):e0181216.

PMID: 28732041 PMC: 5521794. DOI: 10.1371/journal.pone.0181216.


Molecular docking based screening of G6PS with 1, 5 Benzothiazepine derivates for a potential inhibitor.

Chennu M, Abdul R, Yejella R Bioinformation. 2016; 11(12):525-8.

PMID: 26770025 PMC: 4702029. DOI: 10.6026/97320630011525.

References
1.
Hess B, Kutzner C, van der Spoel D, Lindahl E . GROMACS 4:  Algorithms for Highly Efficient, Load-Balanced, and Scalable Molecular Simulation. J Chem Theory Comput. 2015; 4(3):435-47. DOI: 10.1021/ct700301q. View

2.
HESS . Similarities between principal components of protein dynamics and random diffusion. Phys Rev E Stat Phys Plasmas Fluids Relat Interdiscip Topics. 2001; 62(6 Pt B):8438-48. DOI: 10.1103/physreve.62.8438. View

3.
Teplyakov A, Obmolova G, Badet B, Polikarpov I . Involvement of the C terminus in intramolecular nitrogen channeling in glucosamine 6-phosphate synthase: evidence from a 1.6 A crystal structure of the isomerase domain. Structure. 1998; 6(8):1047-55. DOI: 10.1016/s0969-2126(98)00105-1. View

4.
Schuttelkopf A, van Aalten D . PRODRG: a tool for high-throughput crystallography of protein-ligand complexes. Acta Crystallogr D Biol Crystallogr. 2004; 60(Pt 8):1355-63. DOI: 10.1107/S0907444904011679. View

5.
Olchowy J, Gabriel I, Milewski S . Functional domains and interdomain communication in Candida albicans glucosamine-6-phosphate synthase. Biochem J. 2007; 404(1):121-30. PMC: 1868842. DOI: 10.1042/BJ20061502. View